Skip to content
10-K

Annual Report

Cellectar Biosciences, Inc. CLRB

0001104659-26-023167

← back to feed
Filed
Mar 4, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 24, 2026 4.24M sh
Shares Diluted FY 2025 · Dec 31, 2025 2.61M sh
Shares Diluted restated FY 2025 · Dec 31, 2024 1.24M sh
Capex FY 2025 · Dec 31, 2025 $5.88K
Capex FY 2025 · Dec 31, 2024 $104.2K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$23.12M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$47.58M
Cash And Equivalents FY 2025 · Dec 31, 2025 $13.2M
Cash And Equivalents FY 2025 · Dec 31, 2024 $23.29M
Stockholders Equity FY 2025 · Dec 31, 2025 $8.54M
Stockholders Equity FY 2025 · Dec 31, 2024 $14.29M
Current Liabilities FY 2025 · Dec 31, 2025 $4.75M
Current Liabilities FY 2025 · Dec 31, 2024 $9.39M
Total Liabilities FY 2025 · Dec 31, 2025 $5.06M
Total Liabilities FY 2025 · Dec 31, 2024 $9.8M
Current Assets FY 2025 · Dec 31, 2025 $14.04M
Current Assets FY 2025 · Dec 31, 2024 $24.25M
Total Assets FY 2025 · Dec 31, 2025 $14.98M
Total Assets FY 2025 · Dec 31, 2024 $25.47M
Eps Diluted FY 2025 · Dec 31, 2025 −$8.35
Eps Diluted restated FY 2025 · Dec 31, 2024 −$41.89
Eps Basic FY 2025 · Dec 31, 2025 −$8.35
Eps Basic restated FY 2025 · Dec 31, 2024 −$36.52
Sga Expense FY 2025 · Dec 31, 2025 $11.48M
Sga Expense FY 2025 · Dec 31, 2024 $25.64M
Rd Expense FY 2025 · Dec 31, 2025 $11.5M
Rd Expense FY 2025 · Dec 31, 2024 $26.14M
Net Income FY 2025 · Dec 31, 2025 −$21.79M
Net Income FY 2025 · Dec 31, 2024 −$44.58M
Operating Income FY 2025 · Dec 31, 2025 −$22.98M
Operating Income FY 2025 · Dec 31, 2024 −$51.78M